Karama Makni‐Maalej

906 total citations · 1 hit paper
10 papers, 647 citations indexed

About

Karama Makni‐Maalej is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Karama Makni‐Maalej has authored 10 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Karama Makni‐Maalej's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Immune Response and Inflammation (6 papers) and Adenosine and Purinergic Signaling (1 paper). Karama Makni‐Maalej is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Immune Response and Inflammation (6 papers) and Adenosine and Purinergic Signaling (1 paper). Karama Makni‐Maalej collaborates with scholars based in France, Qatar and Algeria. Karama Makni‐Maalej's co-authors include Jamel El‐Benna, Varghese Inchakalody, Maysaloun Merhi, Shahab Uddin, Said Dermime, S Mestiri, Cristina Maccalli, Martin Steinhoff, Francesco M. Marincola and Honar Cherif and has published in prestigious journals such as The Journal of Immunology, Biochemical Pharmacology and Molecular Cancer.

In The Last Decade

Karama Makni‐Maalej

9 papers receiving 637 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

2023 373 citations Karama Makni‐Maalej, Maysaloun Merhi et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karama Makni‐Maalej France	9	355	290	173	99	55	10	647
Edith Uetz‐von Allmen Switzerland	13	396 1.1×	174 0.6×	346 2.0×	37 0.4×	67 1.2×	19	876
JN Rashida Gnanaprakasam United States	11	286 0.8×	144 0.5×	288 1.7×	47 0.5×	49 0.9×	12	671
Christopher M. Rice United Kingdom	5	453 1.3×	101 0.3×	260 1.5×	51 0.5×	36 0.7×	10	720
Marieli Gonzalez-Cotto United States	6	443 1.2×	106 0.4×	258 1.5×	51 0.5×	32 0.6×	10	702
João Paulo Mesquita Luiz Brazil	11	320 0.9×	191 0.7×	232 1.3×	62 0.6×	29 0.5×	23	630
Ya-Lan Guo China	15	311 0.9×	128 0.4×	275 1.6×	30 0.3×	33 0.6×	19	747
Veera Chandra Sekhar Reddy Chittepu Mexico	9	296 0.8×	400 1.4×	214 1.2×	91 0.9×	61 1.1×	12	681
Suzel Davanture France	10	318 0.9×	196 0.7×	226 1.3×	23 0.2×	27 0.5×	12	643
Hongxiang Zeng China	13	186 0.5×	175 0.6×	280 1.6×	103 1.0×	37 0.7×	31	669
Siyuan Xia China	15	215 0.6×	129 0.4×	328 1.9×	28 0.3×	70 1.3×	26	641

Countries citing papers authored by Karama Makni‐Maalej

Since Specialization

Citations

This map shows the geographic impact of Karama Makni‐Maalej's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karama Makni‐Maalej with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karama Makni‐Maalej more than expected).

Fields of papers citing papers by Karama Makni‐Maalej

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karama Makni‐Maalej. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karama Makni‐Maalej. The network helps show where Karama Makni‐Maalej may publish in the future.

Co-authorship network of co-authors of Karama Makni‐Maalej

This figure shows the co-authorship network connecting the top 25 collaborators of Karama Makni‐Maalej. A scholar is included among the top collaborators of Karama Makni‐Maalej based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karama Makni‐Maalej. Karama Makni‐Maalej is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Fernandes, Queenie, S Mestiri, Karama Makni‐Maalej, et al.. (2025). The Internal Ribosome Entry Site in Circular RNAs. Advances in experimental medicine and biology. 1485. 131–148.

Makni‐Maalej, Karama, Maysaloun Merhi, Varghese Inchakalody, et al.. (2023). CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. Molecular Cancer. 22(1). 20–20. 373 indexed citations breakdown →

Taib, Nassiba, Maysaloun Merhi, Varghese Inchakalody, et al.. (2023). Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy. Journal of Translational Medicine. 21(1). 235–235. 13 indexed citations

Makni‐Maalej, Karama, Viviana Marzaioli, Tarek Boussetta, et al.. (2015). TLR8, but not TLR7, induces the priming of the NADPH oxidase activation in human neutrophils. Journal of Leukocyte Biology. 97(6). 1081–1087. 24 indexed citations

Hurtado-Nédelec, Margarita, Karama Makni‐Maalej, Marie‐Anne Gougerot‐Pocidalo, Pham My‐Chan Dang, & Jamel El‐Benna. (2014). Assessment of Priming of the Human Neutrophil Respiratory Burst. Methods in molecular biology. 1124. 405–412. 24 indexed citations

Liu, Miao, Tarek Boussetta, Karama Makni‐Maalej, et al.. (2013). Protectin DX, a Double Lipoxygenase Product of DHA, Inhibits Both ROS Production in Human Neutrophils and Cyclooxygenase Activities. Lipids. 49(1). 49–57. 62 indexed citations

Belambri, Sahra Amel, Margarita Hurtado-Nédelec, Karama Makni‐Maalej, et al.. (2012). Phosphorylation of p47phox is required for receptor-mediated NADPH oxidase/NOX2 activation in Epstein-Barr virus-transformed human B lymphocytes.. PubMed. 2(3). 187–93. 15 indexed citations

Makni‐Maalej, Karama, et al.. (2012). Zymosan induces NADPH oxidase activation in human neutrophils by inducing the phosphorylation of p47phox and the activation of Rac2: Involvement of protein tyrosine kinases, PI3Kinase, PKC, ERK1/2 and p38MAPkinase. Biochemical Pharmacology. 85(1). 92–100. 71 indexed citations

Makni‐Maalej, Karama, Tarek Boussetta, Margarita Hurtado-Nédelec, et al.. (2012). The TLR7/8 Agonist CL097 Primes N-Formyl-Methionyl-Leucyl-Phenylalanine–Stimulated NADPH Oxidase Activation in Human Neutrophils: Critical Role of p47phox Phosphorylation and the Proline Isomerase Pin1. The Journal of Immunology. 189(9). 4657–4665. 39 indexed citations

10.

Dang, Pham My‐Chan, Houssam Raad, Tarek Boussetta, et al.. (2011). The NADPH oxidase cytosolic component p67phox is constitutively phosphorylated in human neutrophils: Regulation by a protein tyrosine kinase, MEK1/2 and phosphatases 1/2A. Biochemical Pharmacology. 82(9). 1145–1152. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact